Jared Leto tops the box office, as the latest Spider-Man spin-off – Morbius – overcomes hostile reviews to make a fair amount of money.
There’s not been a huge wave of affection for the latest movie in Sony’s Spider-Man spin-off cinematic universe. After the success of the two Venom films starring Tom Hardy, the heavily-delayed Morbius, with Jared Leto in the lead, was released at the end of last week, and the critical response was, er, ‘not upbeat’. In fact, very much not upbeat, with some of the worst reviews for a comic book movie in a long, long time.
Yet none of that matters. Critics be damned and such like, as Morbius stormed to the top of the box office charts in the US, with an opening weekend of $39m. That’s neither Venom nor Spider-Man levels of course, but it’s a pretty decent return for a movie that cost in the region of $75m to make.
The film added another $45m or so outside of the US, so should have crossed $100m around the world by the end of the day. Will it be classed as a disappointment? Feasibly, but it’s still doing the kind of numbers that other films in that budget range would be very, very happy with.
Don’t put too much money on Morbius 2 happening though we’d suggest.
Our own review of the film is here.
—
Thank you for visiting! If you’d like to support our attempts to make a non-clickbaity movie website:
Follow Film Stories on Twitter here, and on Facebook here.
Buy our Film Stories and Film Stories Junior print magazines here.
Become a Patron here.
